ICH E2A

E555157

ICH E2A is an International Council for Harmonisation guideline that standardizes clinical safety data management and expedited reporting of adverse drug reactions in clinical trials.

All labels observed (1)

Label Occurrences
ICH E2A canonical 1

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf ICH guideline ⓘ
pharmacovigilance guideline ⓘ
regulatory guideline ⓘ
abbreviationOf International Council for Harmonisation guideline E2A ⓘ
addresses assessment of causality for adverse drug reactions ⓘ
follow-up information for safety reports ⓘ
reporting of fatal or life-threatening events ⓘ
reporting of unexpected serious adverse drug reactions ⓘ
sponsor responsibilities for safety reporting ⓘ
aimsTo provide consistent definitions for safety data in clinical trials ⓘ
reduce duplication of safety reporting requirements across regions ⓘ
appliesTo clinical trials ⓘ
defines adverse drug reaction ⓘ
adverse event ⓘ
expedited report ⓘ
life-threatening adverse drug reaction ⓘ
medically important serious event ⓘ
serious adverse drug reaction ⓘ
serious adverse event ⓘ
unexpected adverse drug reaction ⓘ
focusesOn clinical safety data management ⓘ
expedited reporting of adverse drug reactions ⓘ
fullTitle Clinical Safety Data Management: Definitions and Standards for Expedited Reporting ⓘ
implementedIn European Union pharmacovigilance legislation ⓘ
Japan regulatory safety reporting requirements ⓘ
United States FDA safety reporting regulations for clinical trials ⓘ
issuedBy International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ⓘ
language English ⓘ
objective harmonisation of clinical safety reporting requirements ⓘ
improvement of protection of clinical trial subjects ⓘ
partOf ICH E2 clinical safety guidelines series ⓘ
regulatoryArea human medicines ⓘ
relatedTo ICH E2B ⓘ
ICH E2C ⓘ
ICH E2D ⓘ
ICH E2E ⓘ
scope interventional clinical studies ⓘ
investigational medicinal products in clinical trials ⓘ
standardizes criteria for expedited reporting ⓘ
minimum information for safety reports ⓘ
terminology for clinical safety reporting ⓘ
timelines for expedited reporting ⓘ
usedBy clinical trial sponsors ⓘ
pharmaceutical companies ⓘ
pharmacovigilance professionals ⓘ
regulatory authorities ⓘ

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.